Black Pearl Equities Initiates Tender Offer for Selectis Health Shares

On July 13, 2026, Black Pearl Equities, a prominent investment group based in New York, announced its intentions to purchase all outstanding shares of Selectis Health, Inc. (OTCQB: GBCS). The offer is set at $5.75 per share in cash, marking a significant move in the healthcare sector. Laurel Hill Advisory Group is acting as the Information Agent for this process, which is aimed at consolidating ownership of Selectis Health.

The tender offer is part of a strategic initiative following an Agreement and Plan of Merger dated June 22, 2026, between Black Pearl and Selectis. According to the announcement, the offer is conditional upon the valid tender of at least 70% of Selectis' common stock, along with necessary regulatory approvals. The deadline for this tender offer is set for August 10, 2026, at 5:00 PM New York City time, unless it is extended.

Following the completion of the tender offer, Black Pearl plans to acquire any remaining shares through a merger involving a wholly-owned subsidiary. In this merger, Selectis shareholders will receive the same cash offer of $5.75 per share, excluding any shares owned by certain entities to facilitate the process without a stockholder vote under the Utah Revised Business Corporation Act.

Laurel Hill Advisory has been appointed to handle inquiries from Selectis stockholders regarding the tender offer, including providing additional copies of the Offer to Purchase and related materials. Interested stockholders can reach them at (844) 305-2265.

This move is seen as a strategic acquisition in the healthcare landscape where Selectis Health operates eight facilities in Arkansas and Oklahoma, focusing on skilled nursing care and assisted living services. With support from Medicare, Medicaid, and private pay, Selectis aims to enhance resident care while exploring growth opportunities in the expanding senior healthcare market.

Black Pearl Equities, known for its dynamic investment strategies, expresses confidence that the acquisition will create synergies that benefit all parties involved. The firm thrives on fostering high-impact transactions, and this tender offer showcases their commitment to strategic investments in healthcare.

Stockholders of Selectis Health are being urged to consider this tender offer seriously. The documents related to the tender offer will soon be filed with the U.S. Securities and Exchange Commission (SEC), and it's recommended that stockholders carefully review these materials when they become available, as they contain essential information for making informed decisions regarding their shares.

In summary, Black Pearl's tender offer to acquire Selectis Health at $5.75 per share represents a pivotal moment in the healthcare investment landscape, emphasizing Black Pearl's focus on expanding its portfolio within this critical sector. As the deadline approaches, the actions taken by Selectis shareholders could significantly impact the future trajectory of both companies involved.